FRONTIER CAPITAL MANAGEMENT CO LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$21,511,000
+28.5%
606,968
-51.1%
0.19%
+1.1%
Q1 2020$16,742,000
-34.0%
1,241,977
+3.5%
0.19%0.0%
Q4 2019$25,382,000
+68.9%
1,199,517
+5.9%
0.19%
+59.3%
Q3 2019$15,024,000
+57.5%
1,133,018
+64.8%
0.12%
+63.9%
Q2 2019$9,537,000
-54.3%
687,617
-36.7%
0.07%
-51.4%
Q1 2019$20,859,0001,085,8540.15%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders